Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinqu
- Development stage
- Unknown
- Lead developer
- Yangtze River Pharmaceutical Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Yinqu is a Traditional Chinese Medicine (TCM) preparation, specifically a capsule, developed by Yangtze River Pharmaceutical Group (Nanjing Hailing Pharmaceutical) for the treatment of dyslipidemia. It is a combination product typically composed of extracts from *Ginkgo biloba* leaves and Red Yeast Rice (*Monascus purpureus*). The therapeutic effect is primarily attributed to monacolins (such as monacolin K) found in red yeast rice, which act as HMG-CoA reductase inhibitors to lower cholesterol levels, and ginkgo flavonoids and lactones, which improve blood circulation and provide antioxidant effects. In clinical trials, it has been evaluated for patients presenting with spleen qi deficiency, phlegm, and blood stasis syndrome.
- Brand names
- Yinqu Capsule
- Other names
- Yinqu Jiaonang
02
Targets
HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)
Beyond the preview
Go deeper on Yinqu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yinqu.